Vimarsana
Biggest News Aggregation in the World

Securities Note News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Securities Note. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Securities Note Today - Breaking & Trending Today

Extension of 2024/2025 Offer - Vimarsana News

Extension of 2024/2025 Offer

ProVen VCT plc ProVen Growth and Income VCT plc 10 June 2024 Extension of 2024/2025 Offer On 16 January 2024, ProVen VCT plc and ProVen Growth and Income VCT…

Deutsche Bank : 1st Supplement Registration Document 2024with consolidated Registration Document as supplemented - Vimarsana News

Deutsche Bank : 1st Supplement Registration Document 2024with consolidated Registration Document as supplemented

FIRST SUPPLEMENT DATED 27 MAY 2024 TO THE REGISTRATION DOCUMENT FOR SECONDARY ISSUANCES OF NON-EQUITY SECURITIES DATED...

Pullup Entertainment : Pull Up Entertainment Successfull Capital Increase - Vimarsana News

Pullup Entertainment : Pull Up Entertainment Successfull Capital Increase

This document must not be published, distributed or disseminated, directly or indirectly, in the United States, Canada, Australia or Japan. This press release is a promotional...

PulluP Entertainment PulluP Entertainment successfully completes its capital increase with a priority period and total gross amount of EUR23.08m after full exercise of the extension clause - Vimarsana News

PulluP Entertainment PulluP Entertainment successfully completes its capital increase with a priority period and total gross amount of EUR23.08m after full exercise of the extension clause

DJ PulluP Entertainment successfully completes its capital increase with a priority period and total gross amount of EUR23.08m after full exercise of the extension clause PulluP Entertainment successfully

GenSight Biologics Announces a Successful Offering for an Amount Over €9.2 Million - Vimarsana News

GenSight Biologics Announces a Successful Offering for an Amount Over €9.2 Million

GenSight Biologics shares resume trading today Over €9.2 million offering of ABSA composed of a reserved offering aimed at specialized investors and a private placement More than 50% of the...